New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Reducing harmful proteins in the fight against dementia

Reducing harmful proteins in the fight against dementia

by Jacqueline Pumphrey, Oxford Science Blog,Oxford UniversityWe probably all know someone who has dementia. By 2025, there will be 1 million people affected by it in the UK. Alzheimer's dise
Neurology February 26,2024
Reducing harmful proteins in the fight against dementia

Reducing harmful proteins in the fight against dementia

by Jacqueline Pumphrey, Oxford Science Blog,Oxford UniversityWe probably all know someone who has dementia. By 2025, there will be 1 million people affected by it in the UK. Alzheimer's dise
Neurology February 26,2024
Smart emergency scheme for people with dementia

Smart emergency scheme for people with dementia

by Karlsruhe Institute of TechnologyThe QuartrBack project is to enable social inclusion and freedom of movement in familiar surroundings for people with dementia. Credit: Alexandr Mitiuc / fotal
Neurology February 26,2024
Smart emergency scheme for people with dementia

Smart emergency scheme for people with dementia

by Karlsruhe Institute of TechnologyThe QuartrBack project is to enable social inclusion and freedom of movement in familiar surroundings for people with dementia. Credit: Alexandr Mitiuc / fotal
Neurology February 26,2024
Study reveals new link between Down syndrome and Alzheimer's

Study reveals new link between Down syndrome and Alzheimer's

by Temple UniversityDomenico Praticò, M.D. Credit: The Lewis Katz School of Medicine at Temple UniversityIndividuals with Down syndrome who survive into adulthood face the additional challenge of
Neurology February 26,2024
Study reveals new link between Down syndrome and Alzheimer's

Study reveals new link between Down syndrome and Alzheimer's

by Temple UniversityDomenico Praticò, M.D. Credit: The Lewis Katz School of Medicine at Temple UniversityIndividuals with Down syndrome who survive into adulthood face the additional challenge of
Neurology February 26,2024
Study looks at whether daily limb compressions reduce dementia

Study looks at whether daily limb compressions reduce dementia

by Medical College of GeorgiaDr. David Hess is Chairman of the Department of Neurology at the Medical College of Georgia at Georgia Regents University. Credit: Phil JonesA new study is looking at
Neurology February 26,2024
Study looks at whether daily limb compressions reduce dementia

Study looks at whether daily limb compressions reduce dementia

by Medical College of GeorgiaDr. David Hess is Chairman of the Department of Neurology at the Medical College of Georgia at Georgia Regents University. Credit: Phil JonesA new study is looking at
Neurology February 26,2024
Breakthrough research reveals a new target for Alzheimer's disease treatment

Breakthrough research reveals a new target for Alzheimer's disease treatment

by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
Neurology February 26,2024
Breakthrough research reveals a new target for Alzheimer's disease treatment

Breakthrough research reveals a new target for Alzheimer's disease treatment

by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
Neurology February 26,2024
Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

by Indiana UniversityLeft hemisphere of J. Piłsudski's brain, lateral view. Credit: public domainIn a newly published study, a multi-institutional team led by scientists at the Indiana Univer
Neurology February 26,2024
Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

by Indiana UniversityLeft hemisphere of J. Piłsudski's brain, lateral view. Credit: public domainIn a newly published study, a multi-institutional team led by scientists at the Indiana Univer
Neurology February 26,2024
Brain differences seen in young adults at genetic risk of Alzheimer's

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned
Neurology February 26,2024
Brain differences seen in young adults at genetic risk of Alzheimer's

Brain differences seen in young adults at genetic risk of Alzheimer's

by Amy Norton, Healthday ReporterGenetic risk for Alzheimer’s disease is linked to reduced grid-cell-like representations during virtual navigation. Credit: Created by bureaublauwgeel.nl, commissioned
Neurology February 26,2024
Use of benzodiazepines and related drugs common around Alzheimer's diagnosis

Use of benzodiazepines and related drugs common around Alzheimer's diagnosis

by University of Eastern FinlandUse of benzodiazepines and related drugs common around Alzheimer's diagnosis. Credit: Raija TörrönenBenzodiazepines and related drugs are initiated frequently
Neurology February 26,2024
Use of benzodiazepines and related drugs common around Alzheimer's diagnosis

Use of benzodiazepines and related drugs common around Alzheimer's diagnosis

by University of Eastern FinlandUse of benzodiazepines and related drugs common around Alzheimer's diagnosis. Credit: Raija TörrönenBenzodiazepines and related drugs are initiated frequently
Neurology February 26,2024
Alzheimer's disease consists of three distinct subtypes, according to study

Alzheimer's disease consists of three distinct subtypes, according to study

by Kim Irwin,University of California, Los AngelesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's disease, long thought to be a sin
Neurology February 26,2024
Alzheimer's disease consists of three distinct subtypes, according to study

Alzheimer's disease consists of three distinct subtypes, according to study

by Kim Irwin,University of California, Los AngelesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's disease, long thought to be a sin
Neurology February 26,2024
One in three people born in 2015 will develop dementia, new analysis shows

One in three people born in 2015 will develop dementia, new analysis shows

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's Research UK has renewed its call for urgent action on
Neurology February 26,2024
One in three people born in 2015 will develop dementia, new analysis shows

One in three people born in 2015 will develop dementia, new analysis shows

by Alzheimer's Research UKDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.Alzheimer's Research UK has renewed its call for urgent action on
Neurology February 26,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com